Dr. Schallhorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 San Pablo St
Los Angeles, CA 90033Phone+1 503-494-7674Fax+1 323-442-6338
Education & Training
- University of California (San Francisco)Residency, Ophthalmology, 2010 - 2013
- Huntington Memorial HospitalInternship, Transitional Year, 2009 - 2010
- Keck School of Medicine of the University of Southern CaliforniaClass of 2009
Certifications & Licensure
- OR State Medical License 2014 - Present
- CA State Medical License 2010 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Macular Edema Nepafenac vs. Difluprednate Uveitis Trial Start of enrollment: 2018 Sep 12
- Outpatient Performed Pterygium Surgery Study Start of enrollment: 2020 Mar 01
- Azithromycin for Meibomian Gland Disease Start of enrollment: 2018 Sep 01
Publications & Presentations
PubMed
- 18 citationsSMILE, Topography-Guided LASIK, and Wavefront-Guided LASIK: Review of Clinical Outcomes in Premarket Approval FDA Studies.Julie M. Schallhorn, Stefanie Seifert, Steven C. Schallhorn
Journal of Refractive Surgery. 2019-11-01 - 33 citationsMultifocal and Extended Depth of Focus Intraocular Lenses: A Comparison of Data from the United States Food and Drug Administration Premarket Approval Trials.Julie M. Schallhorn
Journal of Refractive Surgery. 2021-02-01 - 15 citationsPredictors of Patient Satisfaction After Refractive Lens Exchange With an Extended Depth of Focus IOL.Steven C. Schallhorn, Keith A Hettinger, David Teenan, Jan A Venter, Stephen J Hannan
Journal of Refractive Surgery. 2020-03-01
Authored Content
- Nanothin DSAEK, DMEK Yield Comparable Visual OutcomesFebruary 2019
Press Mentions
- Cataract Surgery After LASIKDecember 9th, 2022
- Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic ConjunctivitisOctober 26th, 2020
- Three-Month Outcomes of Laser Vision Correction for Myopia and Hyperopia in Adults with AmblyopiaAugust 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: